Treatment of multidrug-resistant tuberculosis in China

Chemotherapy

Volumn 42, Issue , 1996, Pages 16-19

  Zhang, Li Xing ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Fluoroquinolones; Multidrug resistant tuberculosis; Ofloxacin; Resistance

Indexed keywords

ETHAMBUTOL; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

CHINA; COHORT ANALYSIS; CONFERENCE PAPER; HUMAN; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; TUBERCULOSIS; TUBERCULOSIS CONTROL;

ANTITUBERCULAR AGENTS; CHINA; CLINICAL TRIALS; DRUG THERAPY; FINANCING, ORGANIZED; HEALTH POLICY; HUMANS; INTERNATIONAL COOPERATION; OFLOXACIN; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0029987338     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239509     Document Type: Article

References (8)

1. The Ministry of Public Health of the People's Republic of China: Nationwide Random Survey for Epidemiology of Tuberculosis in 1979.
2. The Ministry of Public Health of the People's Republic of China: Nationwide Random Survey for the Epidemiology of Tuberculosis in 1984/85.
3. The Ministry of Public Health of the People’s Republic of China: Nationwide Random Survey for the Epidemiology of Tuberculosis in 1990.
4. Zhang LX, Kan GQ: Tuberculosis control programme in Beijing. Tubcrc Lung Dis 1992:73:162-166.
5. Qi XQ, Wan LY, Duanmu HJ, Zhao FZ, Song WH: Progress of the National TB Control Programme. Bulletin of the Chinese Anti-Tuberculosis Association 1996;18:5-7.
6. The Ministry of Public Health of the People's Republic of China: The Manual of the National Tuberculo sis Control Programme 1991.
7. Song LZ: Ofloxacin: Advances in Tuberculosis. Guangming Daily Publication 1995; 141-146.
8. Guo XL, Wang CG, Wang LM: Ofloxacin in MDR TB. Bull Chin Antituberc Assoc 1995; 17(suppl): 150-170.